Cholesterol dependent uptake and Interaction of Doxorubicin in MCF-7 breast cancer cells

International Journal of Molecular Sciences

Volumn 14, Issue 4, 2013, Pages 8358-8366

  Weber, Petra ^a   Wagner, Michael ^a   Schneckenburger, Herbert ^a  

^a AALEN UNIVERSITY   (Germany)

Author keywords

Cancer cells; Cholesterol; Doxorubicin; Fluorescence lifetime imaging microscopy (FLIM)

Indexed keywords

CHOLESTEROL; DOXORUBICIN; ANTINEOPLASTIC ANTIBIOTIC;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL KINETICS; CELL LEVEL; CELL STRUCTURE; CELL TRANSPORT; CELLULAR DISTRIBUTION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DRUG RESPONSE; DRUG UPTAKE; FLUORESCENCE IMAGING; FLUORESCENCE LIFETIME IMAGING MICROSCOPY; FLUORESCENCE MICROSCOPY; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; INCUBATION TIME; MOLECULAR DYNAMICS; MOLECULAR IMAGING; MOLECULAR INTERACTION; ACTIVE TRANSPORT; BREAST NEOPLASMS; FEMALE; MCF 7 CELL LINE; MEMBRANE FLUIDITY; METABOLISM; SPECTROFLUOROMETRY;

ANTIBIOTICS, ANTINEOPLASTIC; BIOLOGICAL TRANSPORT, ACTIVE; BREAST NEOPLASMS; CHOLESTEROL; DOXORUBICIN; FEMALE; HUMANS; MCF-7 CELLS; MEMBRANE FLUIDITY; MICROSCOPY, FLUORESCENCE; SPECTROMETRY, FLUORESCENCE;

EID: 84877021850     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14048358     Document Type: Article

References (34)

1. Carter, S.K.; Blum, R.H. New chemotherapeutic agents-Bleomycin and adriamycin. CA Cancer J. Clin. 1974, 24, 322-331.
2. Blum, R.H.; Carter, S.K. Adriamycin. A new anticancer drug with significant clinical activity. Ann. Intern. Med. 1974, 80, 249-259.
3. Li, Z.X.; Wang, T.T.; Wu, Y.T.; Xu, C.M.; Dong, M.Y.; Sheng, J.Z.; Huang, H.F. Adriamycin induces H2AX phosphorylation in human spermatozoa. Asian J. Androl. 2008, 10, 749-757.
4. Karukstis, K.K.; Thompson, E.H.; Whiles, J.A.; Rosenfeld, R.J. Deciphering the fluorescence signature of daunomycin and doxorubicin. Biophys. Chem. 1998, 73, 249-263.
5. Chen, N.T.; Wu, C.Y.; Chung, C.Y.; Hwu, Y.; Cheng, S.H.; Mou, C.Y.; Lo, L.W. Probing the dynamics of doxorubicin-DNA intercalation during the initial activation of apoptosis by fluorescence lifetime imaging microscopy (FLIM). PLoS One 2012, 7, e44947.
6. Bakker, G.J.; Andresen, V.; Hoffman, R.M.; Friedl, P. Fluorescence lifetime microscopy of tumor cell invasion, drug delivery, and cytotoxicity. Methods Enzymol. 2012, 504, 109-125.
7. Dai, X.; Yue, Z.; Eccleston, M.E.; Swartling, J.; Slater, N.K.; Kaminski, C.F. Fluorescence intensity and lifetime imaging of free and micellar-encapsulated doxorubicin in living cells. Nanomedicine 2008, 4, 49-56.
8. Haaland, D.M.; Jones, H.D.; van Benthem, M.H.; Sinclair, M.B.; Melgaard, D.K.; Stork, C.L.; Pedroso, M.C.; Liu, P.; Brasier, A.R.; Andrews, N.L. et al. Hyperspectral confocal fluorescence imaging: Exploring alternative multivariate curve resolution approaches. Appl. Spectrosc. 2009, 63, 271-279.
9. Schneckenburger, H.; Weber, P.; Wagner, M.; Schickinger, S.; Richter, V.; Bruns, T.; Strauss, W.S.; Wittig, R. Light exposure and cell viability in fluorescence microscopy. J. Microsc. 2012, 245, 311-318.
10. Slingerland, M.; Guchelaar, H.J.; Gelderblom, H. Liposomal drug formulations in cancer therapy: 15 years along the road. Drug Discov. Today 2012, 17, 160-166.
11. Opel, D.; Westhoff, M.A.; Bender, A.; Braun, V.; Debatin, K.M.; Fulda, S. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis. Cancer Res. 2008, 68, 6271-6280.
12. Regev, R.; Eytan, G.D. Flip-flop of doxorubicin across erythrocyte and lipid membranes. Biochem. Pharmacol. 1997, 54, 1151-1158.
13. Pacilio, C.; Florio, S.; Pagnini, U.; Crispino, A.; Claudio, P.P.; Pacilio, G.; Pagnini, G. Modification of membrane fluidity and depolarization by some anthracyclines in different cell lines. Anticancer Res. 1998, 18, 4027-4034.
14. Storch, C.H.; Ehehalt, R.; Haefeli, W.E.; Weiss, J. Localization of the human breast cancer resistance protein (BCRP/ABCG2) in lipid rafts/caveolae and modulation of its activity by cholesterol in vitro. J. Pharmacol. Exp. Ther. 2007, 323, 257-264.
15. Peetla, C.; Bhave, R.; Vijayaraghavalu, S.; Stine, A.; Kooijman, E.; Labhasetwar, V. Drug resistance in breast cancer cells: Biophysical characterization of and doxorubicin interactions with membrane lipids. Mol. Pharm. 2010, 7, 2334-2348.
16. Weber, P.; Wagner, M.; Schneckenburger, H. Fluorescence imaging of membrane dynamics in living cells. J. Biomed. Opt. 2010, 15, 046017.
17. von Arnim, C.A.; von Einem, B.; Weber, P.; Wagner, M.; Schwanzar, D.; Spoelgen, R.; Strauss, W.L.; Schneckenburger, H. Impact of cholesterol level upon APP and BACE proximity and APP cleavage. Biochem. Biophys. Res. Commun. 2008, 370, 207-212.
18. Christian, A.E.; Haynes, M.P.; Phillips, M.C.; Rothblat, G.H. Use of cyclodextrins for manipulating cellular cholesterol content. J. Lipid Res. 1997, 38, 2264-2272.
19. Eker, C.; Rydell, R.; Svanberg, K.; Andersson-Engels, S. Multivariate analysis of laryngeal fluorescence spectra recorded in vivo. Lasers Surg. Med. 2001, 28, 259-266.
20. Qu, J.Y.; Chang, H.; Xiong, S. Fluorescence spectral imaging for characterization of tissue based on multivariate statistical analysis. J. Opt. Soc. Am. A 2002, 19, 1823-1831.
21. Xu, X.; Gerard, A.L.; Huang, B.C.; Anderson, D.C.; Payan, D.G.; Luo, Y. Detection of programmed cell death using fluorescence energy transfer. Nucleic Acids Res. 1998, 26, 2034-2035.
22. Angres, B.; Steuer, H.; Weber, P.; Wagner, M.; Schneckenburger, H. A membrane-bound FRET-based caspase sensor for detection of apoptosis using fluorescence lifetime and total internal reflection microscopy. Cytometry A 2009, 75, 420-427.
23. Mulvey, C.S.; Sherwood, C.A.; Bigio, I.J. Wavelength-dependent backscattering measurements for quantitative real-time monitoring of apoptosis in living cells. J. Biomed. Opt. 2009, 14, 064013.
24. Kunz-Schughart, L.A.; Freyer, J.P.; Hofstaedter, F.; Ebner, R. The use of 3-D cultures for high-throughput screening: The multicellular spheroid model. J. Biomol. Screen 2004, 9, 273-285.
25. Pawley, J. Handbook of Biological Confocal Microscopy; Plenum Press: New York, NY, USA, 1990.
26. Webb, R.H. Confocal optical microscopy. Rep. Prog. Phys. 1996, 59, 427-471.
27. Neil, M.A.; Juskaitis, R.; Wilson, T. Method of obtaining optical sectioning by using structured light in a conventional microscope. Opt. Lett. 1997, 22, 1905-1907.
28. Gustafsson, M.G.; Shao, L.; Carlton, P.M.; Wang, C.J.; Golubovskaya, I.N.; Cande, W.Z.; Agard, D.A.; Sedat, J.W. Three-dimensional resolution doubling in wide-field fluorescence microscopy by structured illumination. Biophys. J. 2008, 94, 4957-4970.
29. Huisken, J.; Swoger, J.; Del Bene, F.; Wittbrodt, J.; Stelzer, E.H. Optical sectioning deep inside live embryos by selective plane illumination microscopy. Science 2004, 305, 1007-1009.
30. Santi, P.A. Light sheet fluorescence microscopy: A review. J. Histochem. Cytochem. 2011, 59, 129-138.
31. Bruns, T.; Schickinger, S.; Wittig, R.; Schneckenburger, H. Preparation strategy and illumination of three-dimensional cell cultures in light sheet-based fluorescence microscopyJ. Biomed. Opt. 2012, 17, 101518.
32. Coates, C.G.; Denvir, D.J.; McHale, N.G.; Thornbury, K.D.; Hollywood, M.A. Optimizing low-light microscopy with back-illuminated electron multiplying charge-coupled device: Enhanced sensitivity, speed, and resolution. J. Biomed. Opt. 2004, 9, 1244-1252.
33. Schneckenburger, H.; Wagner, M.; Kretzschmar, M.; Strauss, W.S.; Sailer, R. Laser-assisted fluorescence microscopy for measuring cell membrane dynamics. Photochem. Photobiol. Sci. 2004, 3, 817-822.
34. Wilcoxon, F. Individual comparisons by ranking methods. Biometrics Bull. 1945, 1, 80-83.